Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07323602Recruiting

Predicting DBS Outcomes in Dystonia Using Wearable Gait Sensors

Role: collaborator

NCT05382858Not ApplicableCompleted

PSA Versus STN DBS for TD-PD

Role: collaborator

NCT06752434Not ApplicableRecruiting

PSA Versus STN DBS for DT

Role: collaborator

NCT02440152Phase 2Unknown

The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention

Role: collaborator

NCT02398318Phase 2Withdrawn

China Refractory Obsessive-Compulsive Disorder Deep Brain Stimulation Study

Role: collaborator

All 5 trials loaded